Early co-circulation of different clades of influenza A/H1N1v pandemic virus in Northern Italy by Pariani, Elena et al.
17
J prev med hyg 2011; 52: 17-20
Introduction
Influenza A (family Orthomyxoviridae, genus Influen-
zavirus A) is currently the greatest pandemic disease 
threat to humankind. Influenza A viruses are endowed 
with remarkable biological dynamism and well known 
for their propensity for rapid and unpredictable antigenic 
variation.
In late April 2009, a novel swine-origin influenza 
A/H1N1 virus - A/H1N1v - was identified in humans 
in Mexico and in the USA, initiating the first influenza 
pandemic of the 21st century. Genetic analysis of the 
whole genome of this new virus showed that A/H1N1v 
is a novel reassortant between North American and 
Eurasian swine influenza viruses. The novel virus pos-
sesses the polymerase basic-2 (PB2) and polymerase A 
(PA) genes of North American avian virus origin, the 
polymerase basic-1 (PB1) gene of human H3N2 virus 
origin, the hemagglutinin (HA), nuclear protein (NP) 
and non-structural (NS) genes of classical swine origin 
and the neuraminidase (NA) and matrix (M) genes of 
Eurasian swine virus origin [1]. The virus spread effi-
ciently from person-to-person and on June 11, 2009, the 
World Health Organization (WHO) declared the phase 
6 alert pandemic [2]. As the regional reference labora-
tory operating within the Italian Influenza Surveillance 
Network (INFLUNET, http://www.iss.it/iflu/), we were 
immediately engaged in laboratory surveillance and re-
sponse to influenza pandemic. This gave a unique op-
portunity to examine the pandemic phenomenon using 
both the genetic and the epidemiological approach. The 
large-scale surveillance of A/H1N1v at a molecular lev-
el can be relevant to better define the evolutionary and 
spatial dynamics of this virus in human populations.
The aims of this study were to survey the spatial diffu-
sion over time of A/H1N1v influenza virus in Lombardy 
(Northern Italy, nearly 10 million inhabitants over a to-
tal of about 60 millions at a national level) from April 
to December 2009 and to analyze phylogenetically the 
hemagglutinin gene of A/H1N1v viruses to identify the 
appearance of drift variants.
Methods
In Italy, influenza surveillance is routinely based on a 
nationwide sentinel surveillance network that consists 
of paediatricians and general practitioners, who survey 
approximately 2% of the general population, weekly re-
porting the number of new cases of influenza-like illness 
(ILI), and collecting respiratory samples for virological 
evaluation. The standard case definition of ILI is: abrupt 
onset of fever (> 38.0°C), one or more respiratory symp-
toms (non-productive cough, sore throat, rhinitis) and 
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Introduction. The spatial diffusion over time of pandemic influ-
enza A/H1N1 virus (A/H1N1v) was surveyed in Northern Italy 
(nearly 10 million inhabitants) from April to December 2009, and 
the molecular characteristics of circulating viruses were ana-
lyzed to identify the appearance of drift variants. About 45% of 
analyzed samples were laboratory-confirmed cases of A/H1N1v. 
Sporadic cases occurred until the middle of June 2009, then, case 
numbers began to increase delineating distinct epidemiological 
phases of viral circulation.
Methods. RNA was extracted using RNeasy Mini kit (QIAGEN 
GmbH, Germany). Virological diagnosis of A/H1N1v infection 
was carried out by real-time RT-PCR assay. Sequence analysis 
of hemagglutinin (HA) gene was performed through a RT-PCR 
assay specific for a 995 bp fragment (nt. 64-1,058) in the HA1 
domain. The nucleotide sequences were obtained by automated 
DNA sequencing. The HA1 sequences were aligned with other 
sequences collected from GenBank database by ClustalX soft-
ware. The multiple sequence alignment was used to perform a 
basic phylogenetic analysis and a phylogenetic tree from HA 
sequences was constructed.
Results. The HA gene sequences of A/H1N1v analyzed segregated 
into three genetically distinct clades and were characterized by 
the appearance of amino acid variations that were progressively 
fixed in the field viral population under scrutiny.
Conclusions. These data suggest an early co-circulation of genet-
ically distinct A/H1N1v variants and emphasize the importance of 
a close molecular surveillance to detect rapidly the spread of new 
viral variants and to define their epidemiological impact.
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one or more systemic symptoms (myalgia, headache, 
severe malaise).
By April 26, 2009, surveillance activities were en-
hanced [3] and respiratory samples (nasal-pharyngeal 
swabs) were collected both from hospitalized patients 
suffering from severe ILI and from ILI outpatients. 
Specimens were sent to the regional reference laborato-
ries for virological diagnosis of A/H1N1v infection and 
sequencing. On purpose, total RNA was extracted from 
each specimen using RNeasy Mini kit (QIAGEN GmbH, 
Germany). Virological diagnosis of A/H1N1v infection 
was carried out through a real-time RT-PCR assay [4]. 
Sequence analysis of HA gene was performed in 103 A/
H1N1v viruses through a RT-PCR assay specific for a 
995 bp fragment (nt. 64-1,058) in the HA1 domain [5]. 
Following the RT-PCR of the HA gene, amplicons were 
purified with NucleoSpin® Extract II (Macherey-Nagel 
GmbH, Germany). The nucleotide sequences were ob-
tained by automated DNA sequencing based on fluores-
cent dye terminator on the genetic analyzer ABI PRISM 
3100 (Applied Biosystem, USA). Then, the HA1 se-
quences were aligned with other sequences collected 
from GenBank database by ClustalX software, version 
2.0.12. The multiple sequence alignment was used to 
perform a basic phylogenetic analysis. Phylogenetic tree 
from HA sequences was constructed by means of the 
Neighbor-Joining method and Poisson correction model, 
using MEGA package, version 4.1. A bootstrap analysis 
(n = 1,000) was performed. Sequences were deposited 
into GenBank, National Center for Biotechnology Infor-
mation (NCBI) (http://www.ncbi.nlm.nih.gov), under 
accession numbers GQ14765, GQ246478, GQ259997-
GQ260001, GQ330653-GQ330655, GQ374889, GQ374891, 
GQ374892, GQ422377-GQ422381, GU451262-GU451280, 
GU459082-GU459139, GQ387381-GQ387384, GQ258717, 
GQ166222, and GQ259996. The HA gene sequences used 
in the construction of phylogenetic tree were obtained 
from the NCBI Influenza Virus Sequence Database (ht-
tp://www.ncbi.nlm.nih.gov/Genbank/
index.html). Their accession numbers 
are GQ280797 and FJ969540.
Results
As of 31 December 2009, a total of 
2,685 samples were analyzed and 
1,184 (44.1%) laboratory-confirmed 
cases of pandemic A/H1N1v influen-
za were identified. Of the latter cases 
(median age: 17.1 years; range 15 
days – 86 years), 52.5% were males. 
Figure 1 shows the temporal distribu-
tion of A/H1N1v confirmed cases. 
After the first case of A/H1N1v influ-
enza occurred on May 3, 2009, spo-
radic cases occurred until the middle 
of June. Later on, case numbers began 
to increase delineating distinct epide-
miological phases of viral circulation. 
During the first phase, spanning from 
week 18 to week 24-2009, 14 cases of A/H1N1v in-
fection were laboratory-confirmed. Most (93%) cases 
(median age: 27.6 years; range 24-50 years) were re-
ported among travellers returning from Mexico and 
the USA, while one case was secondary (contact with 
a travel-associated case within seven days of onset). 
During the second epidemiological phase (from week 
25 to week 41-2009), 344 cases (46% males; median 
age: 16.7 years; range 4 months – 84 years) were lab-
oratory-confirmed. Of them, 132 (38.4%) reported a 
history of travel to the UK in the seven days before the 
disease onset, and most of them were teenagers (medi-
an age: 14.7 years; range 3-47 years) attending English 
language summer-schools. Seventy-three (21%) cases 
were reported among travellers returning from a wide 
range of geographical areas (Americas, Oceania, and 
Asia). The first indigenously acquired infection was 
reported on July 16, 2009, and, since then, the number 
of autochthonously acquired cases steadily increased. 
On July 27, 2009, the Italian Ministry of Health de-
creed to stop laboratory confirmation of all probable 
cases [3]. The third epidemiological phase, spanning 
from week 42 to week 52-2009, corresponded to the 
pandemic wave that peaked in week 46-2009. During 
this period, 826 laboratory-confirmed cases (median 
age: 19.4 years; range 15 days – 86 years) were identi-
fied.
The HA sequences of the A/H1N1v viruses analyzed 
fell into three phylogenetically distinct clades (Fig. 2) 
marked by viral variants that appeared at the very be-
ginning of pandemic and then co-circulated in the hu-
man population. All viruses belonging to clade I were 
A/California/07/2009-like and presented T197A ami-
no acid variation in their HA sequences compared to 
A/California/04/2009. Afterwards, this mutation was 
maintained in the viral population under scrutiny. All 
viruses (n = 9) belonging to clade I were identified at the 
very beginning of the pandemic (May-June) in travel-
Fig.1. temporal distribution of a/h1n1v laboratory-confirmed cases in lombardy from 
26 april to 31 december 2009.
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lers returning from affected areas (Mexico, the USA and 
the UK). By the beginning of June, a new viral variant 
characterized by a further amino acid change (S203T) 
was identified and became representative of sequences 
(n = 46) included in clade II. The observed amino acid 
mutation was maintained in the viral population and this 
new variant co-circulated with the one previously rec-
ognized. Thirty-three (71.7%) sequences within clade II 
were identified in viral strains found in subjects return-
ing from different geographic areas (Americas, Oceania, 
and Asia). The remaining thirteen (28.3%) sequences 
were identified in patients who did not travel abroad 
(autochthonous acquired disease). Clade II included 
sequences of viruses identified during the whole study 
period (from May to December 2009). From early July 
(week 27-2009), a novel viral variant, presenting the 
amino acid change D222E, was observed. This muta-
tion, characterizing sequences (n = 48) included in clade 
III, fell in the HA receptor binding site and in the Ca2 
epitope [6]. Twenty-eight (58.3%) viruses belonging to 
clade III were identified in autochthonous cases, while 
the remaining twenty (41.7%) in travellers returning 
from journeys in Europe. Clade III included sequences 
of viruses identified during the second and third epide-
miological phase only (August-December).
Several mutations were observed at single-sequence level 
and occurred sporadically, suggesting that they were not 
fixed in the viral population under analysis. Altogether, 
all A/H1N1v viruses were antigenically characterized 
and resulted to be similar to A/California/07/2009, the 
WHO recommended vaccine strain.
Discussion
This study showed an early segregation of pandem-
ic A/H1N1v influenza viruses in three distinct clades. 
Several viral variants were identified from the very 
beginning of the pandemic both in travellers returning 
from affected areas and in indigenous cases. This outline 
suggests that distinct viral variants appeared almost si-
multaneously in different geographical areas (Americas, 
Asia, Europe, and Oceania), and rapidly spread globally 
co-circulating over time and space.
The HA sequences of these viruses segregated into 
three distinct clades characterized by amino acid 
changes, which were fixed progressively in the viral 
population. A whole-genome phylogenetic analysis of 
A/H1N1v isolates collected globally [7] has revealed 
that at least seven major clades of the A/H1N1v in-
fluenza virus have co-circulated over time and space 
since April 2009. This study has demonstrated that, 
very early in its history, A/H1N1v virus has evolved, 
shifting from an initial mixed clade pattern to the pre-
dominance of one clade (clade 7) during the course 
of the pandemic. The viruses constituting this clade 
substituted all other clades in the later phases of the 
pandemic and become responsible for most of the pan-
demic burden worldwide [8]. Our findings, though rel-
evant to a restricted area, showed a similar chronologi-
Fig. 2. ha1 phylogenetic tree. Sequences from the first epide-
miological phase (may-June 2009) are labelled in light grey, the 
ones from the second epidemiological phase (July-august 2009) 
are labelled in dark grey, and the ones from the third phase (Sep-
tember-december 2009) are labelled in black. major amino acid 
changes are reported in block letters.
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cal evolution of A/H1N1v virus. In fact, in agreement 
with these previous studies, the analysis carried out in 
our study indicated that the dominant A/H1N1v virus 
in Lombardy was clade 7. Indeed, the majority (91.3%) 
of analyzed sequences presented the amino acid change 
S203T in their HA, which is the hallmark of sequences 
constituting clade 7. Whether the predominance of this 
clade in the surveyed area is related to the adaptability 
of the virus or to a more efficient human transmissibility 
over other early clades has yet to be demonstrated. It is 
unclear whether differences in fitness or clinical severity 
exist among these co-circulating lineages, since no clear 
trend in the clinical aspects could be observed between 
the early and the late peaks of the epidemic [9]. Neither 
was a clear clinical impact demonstrated for HA variants. 
D222G/N substitutions [10] were observed sporadically 
with no evidence of their maintenance in the local viral 
population. In particular, the D222G mutation, whose 
significance in terms of pathogenicity needs to be veri-
fied, was detected in only one of the study sequences.
Overall, though several amino acid mutations were ob-
served at or near the HA antigenic sites, all A/H1N1v 
viruses circulating in Northern Italy appeared to be an-
tigenically related to A/California/07/2009 strain, thus 
potentially having no subsequent implications to vac-
cine efficacy.
Conversely, though a major limitation of our study is to 
provide data representing a restricted reflection of the 
evolution of the pandemic influenza A/H1N1v, our find-
ings mostly replicate what has been described by oth-
ers [7, 8], thus confirming the major evolutionary fea-
tures of the pandemic influenza virus.
Conclusions
In conclusion, our data suggest an early co-circulation of 
genetically distinct A/H1N1v variants. Thus, a continu-
ous molecular surveillance to detect rapidly the spread 
of new viral variants and to evaluate their epidemiologi-
cal impact is critical.
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